Placebo News and Research

RSS

New vaccine that targets avian flu

Vanderbilt University Medical Center is enrolling volunteers in a study to test a new vaccine that targets avian flu, the first such vaccine against the virus.

30 Oct 2005

Rimonabant appears to be very promising, especially for the treatment of patients with abdominal obesity

Overweight or obese people who are stout around the waist and abdomen are particularly at high risk for developing type 2 diabetes and high blood pressure.

30 Oct 2005

Little evidence exists to support the widespread use of bronchodilators to treat children and adults with cystic fibrosis

"Recurrent wheeze and breathlessness are common in people with cystic fibrosis, and bronchodilators are commonly prescribed," according to lead author Clare Halfhide, M.D., of the Royal Liverpool Children's Hospital in England. "Despite their wide-scale and often long-term use, there is limited objective evidence about their efficacy in cystic fibrosis."

25 Oct 2005

Women's sexual function improves when partners are administered Vardenafil for erectile dysfunction

Couples share wine, movies, vacations and bedrooms. Do couples also share sexual problems and solutions?

25 Oct 2005

Viagra significantly reduces stress on the heart

According to the results of a new study by researchers at Johns Hopkins, Viagra, a drug used to treat erectile dysfunction (ED) in millions of men, reduces the stimulatory effects of hormonal stress on the heart by half.

25 Oct 2005

COLD-fX reduces colds

The results of a new study to be published in the Canadian Medical Association Journal show that COLD-fX, an anti-flu, anti-cold pill, reduced the incidence and frequency of recurrent colds by more than half. It also cut the duration of colds and significantly reduced their severity.

25 Oct 2005

Ginseng shown to significantly offer protection from colds

According to new research people who take ginseng suffer from far fewer colds.

25 Oct 2005

Viagra may be the next drug treatment for heart problems

Sildenafil citrate (Viagra), a drug used to treat erectile dysfunction (ED) in millions of men, reduces the stimulatory effects of hormonal stress on the heart by half, according to results of a new study by researchers at Johns Hopkins.

24 Oct 2005

Botulinum toxin successfully treats trigeminal neuralgia

There is another use for botulinum toxin which has brought relief to some who suffer from migraines and eye spasms. Botulinum toxin can also successfully treat intense facial pain called trigeminal neuralgia, according to a study published in the October 25, 2005, issue of Neurology

24 Oct 2005

Traditional medical treatment of persistent cough may not be the most effective

The reviews appear in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

23 Oct 2005

Intravenous lidocaine and oral derivatives relieve pain from damage to the nervous system

Lidocaine and similar local anesthetics are effective for treating pain that emanates from damaged nerves, according to a systematic review of current evidence.

23 Oct 2005

Study of the effects of aripiprazole, olanzapine, quetiapine and risperidone, in elderly patients with dementia

Some newer antipsychotic medications may be associated with a small increased risk of death when used to treat elderly dementia patients, psychiatrists at Johns Hopkins warn.

18 Oct 2005

Atypical antipsychotic drugs slightly increase risk for death when used in people with dementia

Atypical antipsychotic drugs seem to confer a small increased risk for death when used in people with dementia, concludes a team of researchers from the Keck School of Medicine of the University of Southern California in a meta-analysis of 15 clinical trials published in the October 19 issue of the JAMA: The Journal of the American Medical Association.

18 Oct 2005

Expert evaluates orlistat (Xenical)

A 60 mg low-dose version of the prescription weight-loss medication orlistat (marketed by GlaxoSmithKline as Xenical 120 mg) was found to be safe, effective and tolerable in overweight individuals, according to new data presented today at the 2005 Annual Meeting of NAASO, The Obesity Society in Vancouver, British Columbia.

18 Oct 2005

dnaJP1 - novel drug for the treatment of rheumatoid arthritis

Researchers at the University of California, San Diego (UCSD) School of Medicine have announced successful completion of Phase II clinical trials of a novel drug for the treatment of rheumatoid arthritis (RA), one that works without suppressing the patient's immune system.

16 Oct 2005

Ebixa (memantine) approved for the treatment of moderate Alzheimer's disease

The Committee for Medicinal Products for Human Use (CHMP) has announced its decision to extend Ebixa’s current indication (moderately severe to severe disease) to include moderate stages of Alzheimer’s disease (AD).

16 Oct 2005

Remicade can improve psoriasis symptoms

An international team led by a dermatologist at The University of Manchester has found that treatment with the emerging drug infliximab, marketed as Remicade, can quickly and significantly improve psoriasis symptoms.

From The University of Manchester 13 Oct 2005

Experimental HIV vaccine progresses in trials

A novel vaccine targeted to multiple HIV subtypes found worldwide has moved into the second phase of clinical testing, the National Institute of Allergy and Infectious Diseases (NIAID) announced today.

11 Oct 2005

100% efficacy for cervical cancer vaccine

Final-stage clinical trials of a cervical cancer vaccine developed by University of Queensland (UQ) scientists, have shown the drug to be 100 per cent effective.

10 Oct 2005

Actos reduces the combined risk of non-fatal heart attacks, strokes in patients with type-2 diabetes

A study published in The Lancet shows that Takeda's Actos (pioglitazone HCl), an oral glucose lowering medication, significantly reduces the combined risk of non-fatal heart attacks, strokes and deaths by an additional 16% on top of standard medication

10 Oct 2005

Placebo News and Research

New vaccine that targets avian flu

Rimonabant appears to be very promising, especially for the treatment of patients with abdominal obesity

Little evidence exists to support the widespread use of bronchodilators to treat children and adults with cystic fibrosis

Women's sexual function improves when partners are administered Vardenafil for erectile dysfunction

Viagra significantly reduces stress on the heart

COLD-fX reduces colds

Ginseng shown to significantly offer protection from colds

Viagra may be the next drug treatment for heart problems

Botulinum toxin successfully treats trigeminal neuralgia

Traditional medical treatment of persistent cough may not be the most effective

Intravenous lidocaine and oral derivatives relieve pain from damage to the nervous system

Study of the effects of aripiprazole, olanzapine, quetiapine and risperidone, in elderly patients with dementia

Atypical antipsychotic drugs slightly increase risk for death when used in people with dementia

Expert evaluates orlistat (Xenical)

dnaJP1 - novel drug for the treatment of rheumatoid arthritis

Ebixa (memantine) approved for the treatment of moderate Alzheimer's disease

Remicade can improve psoriasis symptoms

Experimental HIV vaccine progresses in trials

100% efficacy for cervical cancer vaccine

Actos reduces the combined risk of non-fatal heart attacks, strokes in patients with type-2 diabetes

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News